Tirzepatide
SURMOUNT-OSA
Eli Lilly · Phase 3 · Completed · Enrollment 469
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Tirzepatide
Eli Lilly · Phase 3 · Completed · Enrollment 469
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.